Mifepristone inhibits the expression of vascular endothelial growth factor through glucocorticoid receptor signalling pathway in prostate cancer cell line PC-3

ZHANG Hui,WANG Yu-qiu,ZHANG Jie,MA Chun-yan,LU Jia-ju

DOI: https://doi.org/10.3781/j.issn.1000-7431.2011.08.007

2011-01-01

Tumor

Abstract:Objective: To investigate the role of glucocorticoid receptor (GR) signalling pathway in the expression of vascular endothelial growth factor (VEGF) inhibited by mifepristone in prostate cancer cell line PC-3. Methods: The expression of GR in prostate cancer cell line PC-3 was determined by immunocytochemical technique. After treatment with different concentrations of mifepristone for 48 h, the expression change of GR mRNA was evaluated by using RT-PCR. The expression level of VEGF protein in PC-3 cells was detected by using ELISA after treatment with different concentrations of mifepristone for different time or different hormones. Results: Immunocytochemical analysis revealed the expression of GR in PC-3 cells. The expression level of GR mRNA in PC-3 cells treated with 5, 10 or 50 μmol/L mifepristone exhibited a descending trend. The expression of GR mRNA in PC-3 cells treated with 5 μmol/L mifepristone for 48 h was similar to that of the untreated PC-3 cells (P>0.05), but the expression of GR mRNA in PC-3 cells treated with 10 or 50 μmol/L of mifepristone for 48 h was significantly different from that of the untreated PC-3 cells (P<0.01). The secretion level of VEGF was gradually down-regulated in PC-3 cells treated with 1 μmol/L to 100 μmol/L of mifepristone for 48 h. Mifepristone at 10 μmol/L down-regulated the level of VEGF secretion by 48.29%, as compared with that of the untreated PC-3 cells. The level of VEGF secretion was gradually Mifepristone inhibits the expression of vascular endothelial growth factor through glucocorticoid receptor signalling pathway in prostate cancer cell line PC-3 ZHANG Hui1, Wang Yu-qiu1, ZHANG Jie2, MA Chun-yan2, Lü Jia-ju1 1. Department of Urology, 2. Central Laboratory, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China Abstract Objective: To investigate the role of glucocorticoid receptor (GR) signalling pathway in the expression of vascular endothelial growth factor (VEGF) inhibited by mifepristone in prostate cancer cell line PC-3. Methods: The expression of GR in prostate cancer cell line PC-3 was determined by immunocytochemical technique. After treatment with different concentrations of mifepristone for 48 h, the expression change of GR mRNA was evaluated by using RT-PCR. The expression level of VEGF protein in PC-3 cells was detected by using ELISA after treatment with different concentrations of mifepristone for different time or different hormones. Results: Immunocytochemical analysis revealed the expression of GR in PC-3 cells. The expression level of GR mRNA in PC-3 cells treated with 5, 10 or 50 μmol/L mifepristone exhibited a descending trend. The expression of GR mRNA in PC-3 cells treated with 5 μmol/L mifepristone for 48 h was similar to that of the untreated PC-3 cells (P>0.05), but the expression of GR mRNA in PC-3 cells treated with 10 or 50 μmol/L of mifepristone for 48 h was significantly different from that of the untreated PC-3 cells (P<0.01). The secretion level of VEGF was gradually down-regulated in PC-3 cells treated with 1 μmol/L to 100 μmol/L of mifepristone for 48 h. Mifepristone at 10 μmol/L down-regulated the level of VEGF secretion by 48.29%, as compared with that of the untreated PC-3 cells. The level of VEGF secretion was gradually decreased in PC-3 cells treated with 10 μmol/L mifepristone for 24 h to 96 h. Mifepristone treatment for 48 h decreased the level of VEGF secretion by 48.23%, which was significantly different from that of the untreated PC-3 cells (P<0.01). In PC-3 cells which were treated with different hormones, only mifepristone could reduce the level of VEGF secretion (P<0.01). However, progesterone could slightly elevate the level of VEGF secretion, but the other hormones showed no such effects. Dexamethasone could block the inhibition effect of mifepristone on the level of VEGF secretion in PC-3 cells. Conclusion: Mifepristone can inhibit the secreation of VEGF protein in prostate cancer PC-3 cells which may be through GR signalling pathway in vitro.